IP Library › Granted Patent US 12,350,321
Granted Patent B2
US 12,350,321 · App. 18/431,596 · Granted Jul 8, 2025

Fibroin-derived protein composition

Inventors: Brian D. Lawrence (Plymouth, MN); David W. Infanger (Plymouth, MN)
Assignee: SILK TECHNOLOGIES, LTD.
A61K38/39A23J3/00A23L2/66A23L33/17A61K35/64A61K45/06C07K14/78A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,350,321
App. No.
18/431,596
Granted
Jul 8, 2025
Kind
B2
Abstract

A protein composition derived from silk fibroin, which composition possesses enhanced solubility and stability in aqueous solutions. The primary amino acid sequence of native fibroin is modified in the SDP such that cysteine disulfide bonds between the fibroin heavy and fibroin light protein chains are reduced or eliminated. Additionally, the composition can have a serine content that is reduced by greater than 40% compared to native fibroin protein, and the average molecular weight of the SDP is less than about 100 kDa.

Claims (16)

1. A fibroin-derived protein composition prepared by a process comprising heating an aqueous fibroin solution at an elevated pressure, wherein:

the aqueous fibroin solution comprises lithium bromide at a concentration of at least about 8M, and the aqueous fibroin solution is heated to at least about 105° C. (221° F.) under a pressure of about 10 PSI to about 20 PSI for at least about 20 minutes in the presence of the lithium bromide;

to provide a protein composition comprising fibroin-derived protein wherein:

the primary amino acid sequences of the fibroin-derived protein composition differ from native fibroin by at least 6% with respect to the combined amino acid content of serine, glycine, and alanine, based on the combined absolute values of the differences in the content of serine, glycine, and alanine;

cysteine disulfide bonds between the fibroin heavy and fibroin light protein chains of fibroin are reduced or eliminated;

the protein composition has a serine content that is reduced by greater than 25% compared to native fibroin protein, wherein the protein composition comprises between 4.5% and 7.5% serine amino acids residues;

wherein the average molecular weight of the fibroin-derived protein composition is less than about 100 kDa; and

wherein the protein composition has an aqueous viscosity of less than 5 cP as a 10% w/w solution in water.

2. The protein composition of claim 1 wherein the aqueous fibroin solution is heated to a temperature of about 115° C. (239° F.) to about 125° C. (257° F.) under a pressure of about 15 PSI to about 20 PSI for at least about 30 minutes.

3. The protein composition of claim 1 wherein the fibroin-derived protein has an average molecular weight of less than about 60 kDa.

4. The protein composition of claim 1 wherein the protein composition has an aqueous viscosity of less than 10 cP as a 24% w/w solution in water.

5. The protein composition of claim 1 wherein a primary amino acid sequences of the fibroin-derived protein differ from native fibroin by at least 8% with respect to the combined amino acid content of serine, glycine, and alanine based on a combined absolute values of the differences in the content of serine, glycine, and alanine.

6. The protein composition of claim 1 wherein the fibroin-derived protein comprises greater than 46.5% glycine amino acids.

7. The protein composition of claim 6 wherein the fibroin-derived protein comprises greater than 48% glycine amino acids.

8. The protein composition of claim 1 wherein the fibroin-derived protein comprises greater than 30% alanine amino acids.

9. The protein composition of claim 8 wherein the fibroin-derived protein comprises greater than 31.5% alanine amino acids.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 29, 2024
From: LAWRENCE, BRIAN D.; INFANGER, DAVID W.
To: SILK TECHNOLOGIES, LTD.
Reel/Frame 066608/0148 →
Continuity (8)
Division 17360674 · Jun 28, 2021
Continuation 16680186 · Nov 11, 2019
Continuation 15912295 · Mar 5, 2018
Continuation 15212086 · Jul 15, 2016
Continuation 14831473 · Aug 20, 2015
Provisional Application 62193790 · Jul 17, 2015
Provisional Application 62039675 · Aug 20, 2014
Related Publication 20240216478A1 · Jul 4, 2024
References Cited (93)
US 5591426A · Dabrowski et al. · 1997 [cited by applicant]
US 5895645A · Dabrowski et al. · 1999 [cited by applicant]
US 6034220A · Stedronsky · 2000 [cited by applicant]
US 6280747B1 · Philippe et al. · 2001 [cited by applicant]
US 7060260B2 · Fahnestock et al. · 2006 [cited by applicant]
US 7115388B2 · Tsubouchi · 2006 [cited by applicant]
US 7193038B2 · Tsubouchi et al. · 2007 [cited by applicant]
US 7635755B2 · Kaplan et al. · 2009 [cited by applicant]
US 8097583B2 · Scheibel et al. · 2012 [cited by applicant]
US 8361617B2 · Kaplan et al. · 2013 [cited by applicant]
US 8420077B2 · Altman et al. · 2013 [cited by applicant]
US 8481681B2 · Sutherland et al. · 2013 [cited by applicant]
US 8496976B2 · Gore et al. · 2013 [cited by applicant]
US 8614293B2 · Kaplan et al. · 2013 [cited by applicant]
US 8742069B2 · Kaplan et al. · 2014 [cited by applicant]
US 9394355B2 · Lawrence · 2016 [cited by examiner]
US 9907836B2 · Lawrence · 2018 [cited by examiner]
US 10471128B2 · Lawrence · 2019 [cited by examiner]
US 11045524B2 · Lawrence · 2021 [cited by examiner]
US 11242367B2 · Lawrence et al. · 2022 [cited by applicant]
US 20030206897A1 · O'prey et al. · 2003 [cited by applicant]
US 20040097709A1 · Armato et al. · 2004 [cited by applicant]
US 20040219630A1 · Tsubouchi · 2004 [cited by applicant]
US 20040265260A1 · Tsubouchi et al. · 2004 [cited by applicant]
US 20050143296A1 · Tsubouchi et al. · 2005 [cited by applicant]
US 20050196370A1 · Yu et al. · 2005 [cited by applicant]
US 20050202097A1 · Maskin · 2005 [cited by applicant]
US 20060106104A1 · Vehige et al. · 2006 [cited by applicant]
US 20080219938A1 · Grune · 2008 [cited by applicant]
US 20090234026A1 · Kaplan et al. · 2009 [cited by applicant]
US 20110008406A1 · Altman et al. · 2011 [cited by applicant]
US 20110105402A1 · Kim et al. · 2011 [cited by applicant]
US 20110288273A1 · Yang et al. · 2011 [cited by applicant]
US 20120040907A1 · DiBenedetto et al. · 2012 [cited by applicant]
US 20120052124A1 · Kaplan et al. · 2012 [cited by applicant]
US 20120171256A1 · Zhang et al. · 2012 [cited by applicant]
US 20130039986A1 · Kaplan et al. · 2013 [cited by applicant]
US 20130060008A1 · Wang et al. · 2013 [cited by applicant]
US 20130158131A1 · Kaplan et al. · 2013 [cited by applicant]
US 20130165004A1 · Kaplan et al. · 2013 [cited by applicant]
US 20130190222A1 · Kaplan et al. · 2013 [cited by applicant]
US 20130243693A1 · Omenetto et al. · 2013 [cited by applicant]
US 20130243709A1 · Hanson et al. · 2013 [cited by applicant]
US 20140193466A1 · Lawrence et al. · 2014 [cited by applicant]
US 20140235554A1 · Lawrence et al. · 2014 [cited by applicant]
US 20150093340A1 · Altman et al. · 2015 [cited by applicant]
US 20160096878A1 · Lawrence et al. · 2016 [cited by applicant]
CN 101194666A · 2008 [cited by applicant]
CN 102860969A · 2013 [cited by applicant]
CN 103239707A · 2013 [cited by applicant]
CN 103225126B · 2014 [cited by applicant]
JP S55124793A · 1980 [cited by applicant]
JP H02277885A · 1990 [cited by applicant]
JP 0767686A · 1995 [cited by applicant]
JP H08295697A · 1996 [cited by applicant]
JP 2000143472A · 2000 [cited by applicant]
WO 1999033899A1 · 1999 [cited by applicant]
WO 2007130364A2 · 2007 [cited by applicant]
WO 2009088119A1 · 2009 [cited by applicant]
WO 2012170655A1 · 2012 [cited by applicant]
WO 2013126799A1 · 2013 [cited by applicant]
WO 2013159101A1 · 2013 [cited by applicant]
WO 2014145002A2 · 2014 [cited by applicant]
WO 2014145002A3 · 2014 [cited by applicant]
WO 2014152097A1 · 2014 [cited by applicant]
WO 2015077300A1 · 2015 [cited by applicant]
WO 2016100721A1 · 2016 [cited by applicant]
Applegate et al., “Photocrosslinking of Silk Fibroin Using Riboflavin for Ocular Prostheses,” Adv Mater., 28 (12):2417-2420, Mar. 2016. [cited by applicant]
Asakura et al., “Possible Implications of Serine and Tyrosine Residues and Intermolecular Interactions on the Appearance of Silk I Structure of Bombyx Mori Silk Fibroin-Derived Synthetic Peptides: High-Resolution 13C Cr… [cited by applicant]
Chon et al., “Silk Fibroin Hydrolysate Inhibits Osteoclastogenesis and Induces Apoptosis of Osteoclasts Derived from RAW 264.7 Cells,” Int J Mol Med., 30(5):1203-1210, Nov. 2012. [cited by applicant]
Collin et al., “Molecular Evolution of Lepidopteran Silk Proteins: Insights from the Ghost Moth, Hepialus californicus,” J Mol Evol., 70:519-529; May 2010. [cited by applicant]
Daithankar et al., “Moisturizing Efficiency of Silk Protein Hydrolysate: Silk Fibroin,” Indian J. Biotech., 4:115-121: Jan. 4, 2005. [cited by applicant]
Extended Search Report of the European Patent Office dated Apr. 24, 2018 in EP Application No. 15833824.4.6 (EP3182985A1), 7pgs. [cited by applicant]
Greving et al., “Shear-Induced Self-Assembly of Native Silk Proteins into Fibrils Studied by Atomic Force Microscopy,” Biomacromolecules, 13(3):676-682, Feb. 21, 2012. [cited by applicant]
Hardy et al., “Polymeric Materials Based on Silk Proteins,” Polymer, 49(20):4309-4327, Sep. 2008. [cited by applicant]
Harkin et al., “Silk Fibroin in Ocular Tissue Reconstruction,” Biomaterials, 32(10):2445-58, Apr. 2011. [cited by applicant]
Hashimoto et al., “Quantitative Evaluation of Fibroblast Migration on a Silk Fibroin Surface and TGFBI Gene Expression,” J Biomater Sci Polym Ed., 24(2):158-169, Jan. 2013. [cited by applicant]
International Search Report and Written Opinion of the ISA/US dated Dec. 14, 2015 in International Application No. PCT/US2015/046141; 17pgs. [cited by applicant]
International Search Report and Written Opinion of the ISA/US dated Dec. 22, 2017 in International Application No. PCT/US2017/026656; 12pgs. [cited by applicant]
International Search Report and Written Opinion of the ISA/US dated Dec. 4, 2017 in International Application No. PCT/US2017/046659; 11pgs. [cited by applicant]
Kang et al., “Preparation and Characterization of Low Molecular Weight Silk Fibroin by High-Temperature and High-Pressure Method,” J. Applied Polymer Sci., 85(14):2890-2895, Sep. 2002. [cited by applicant]
Kaur et al., “Photoprotection by Silk Cocoons,” Biomacromolecules, 14(10):3660-3667, Sep. 3, 2013. [cited by applicant]
Kim et al., “A Transparent Artificial Dura Mater Made of Silk Fibroin as an Inhibitor of Inflammation in Craniotomized Rats,” J Neurosurg., 114(2):485-490, Feb. 2011. [cited by applicant]
Lawrence et al., “Silk Film Culture System for in vitro Analysis and Biomaterial Design,” J Vis Exp., 62:1-6, Apr. 2012. [cited by applicant]
Matsumoto et al., “Mechanisms of Silk Fibroin Sol-Gel Transitions,” J Phys Chem B., 110(43):21630-2638, Nov. 2, 2008. [cited by applicant]
Patchornik et al., “Nonenzymatic Cleavages of Peptide Chains at the Cysteine and Serine Residues Through Their Conversion Into Dehydroalanine. I. Hydrolytic and Oxidative Cleavage of Dehydroalanine Residues,” J. Am. Che… [cited by applicant]
Rockwood et al., “Materials Fabrication from Bombyx mori Silk Fibroin,” Nat Protoc., 6(10):1612-1631, Sep. 2011. [cited by applicant]
Siritientong et al., “The effects of Bombyx mori silk strain and extraction time on the molecular and biological characteristics of sericin,” Bioscience, Biotechnology, and Biochemistry., vol. 80, No. 2, 241-249; Aug. 2… [cited by applicant]
Teng et al., “Physical Crosslinking Modulates Sustained Drug Release from Recombinant Silk-Elastinlike Protein Polymer for Ophthalmic Applications,” J. Control Release, 156(2):186-197, Dec. 2011. [cited by applicant]
Wang et al., “Sonication-Induced Gelation of Silk Fibroin for Cell Encapsulation,” Biomaterials, 29(8):1054-1064, Apr. 2008. [cited by applicant]
Wu et al., “Impact of Sterilization Methods on the Stability of Silk Fibroin Solution,” Adv Mater Res., 311-313:1755-1759, Aug. 2011. [cited by applicant]
Yamada et al., “Preparation of Undegraded Native Molecular Fibroin Solution from Silkworm Cocoons,” Mater Sci Eng.: C, 14(1-2):41-46, Aug. 2001. [cited by applicant]
Zhao et al., “The Effects of Different Sterilization Methods on Silk Fibroin,” J Biomed Sci Eng., 4:397-402, May 2011. [cited by applicant]